She is an Associate Professor of the Department Hematology, Hemostasis and Oncology at Hannover Medical School. She graduated in Medicine from the University of Vienna, Medical Faculty and received her MD degree (Dr. med. univ.) in 1987. After a postdoctoral training at the heart surgery department (University of Vienna) and at the National Institutes of Health (USA, 1989-1993), she obtained her "Habilitation" in Munich (1993-1998) in the field of experimental haematology. She was an invited scientist to the National Heart, Blood and Lung Institute at NIH (1998-1999) and joined Hannover Medical School in 1999. From 2002 to 2004 she was chief medical officer in a privately held start up company (mosaiques) and since 2004 she is group leader at the Department of Hematology, where she was appointed APL-Prof. in 2005.
Research interests and achievements:
Eva M. Weissinger initially worked in the field of understanding the interaction of oncogenes during the transformation of hematopoietic cells (v-abl and c-myc) using retroviral gene transfer for expression of the oncogenes. Her research focuses now on complications occurring after hematopoietic stem cell transplantation, such as graft versus host disease (GvHD) and viral reactivations (e.g. cytomegalovirus, CMV). One of her main goals is the application of proteomic screening to detect changes in body fluids prior to the development of complications. Using capillary electrophoreses coupled on-line to an electrospray time of flight mass spectrometer she could identify early markers for the development of GvHD and was awarded for this work with the "Rudolf-Schön-Award" in 2004.
Her research is funded by the German-Jose-Carreras- Leukemia foundation (Deutsche-Jose-Carreras-Leukämie –Stiftung), The European Community, the German Mildreed Scheel foundation for Cancer Research and the German Research society (DFG). She has participated in several European Studies (Biomed 2 and 3 and FP5 SGT in SCT).